http://www.bullseyestox.com/ Bullseyestox is a service that writes about Companies and disseminate the information to our members via email. We adopt various strategies that are fitting for the securities that we trade. Most of our penny stock picks are pro-bono and are based on technical... More
Keryx Biopharmaceuticals, Inc. (KERX) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.
This stock has had its share of gyrations. It has a 52 week high of around $5.55 and has a bunch of followers and investors who are enthusiastic about its KRX-0401 (perifosine), an oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K).
Note that the stock did not move based on the KRX-0401 today. KERX moved today on news about their drug Zerenex (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. Zenerex got a positive review from a study in Japan thereby causing the stock to react positively. Is there more in the tank?
This stock has a 200 day moving average of $3.27, and a 50 day moving average of $3.23. Can the stock rally back to these levels on this positive study?
Sign up for our newsletter and get our charts and profiles today!
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha
community. Instablog posts are not selected, edited or screened by Seeking Alpha editors,
in contrast to contributors' articles.
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
KERX Chart 0 comments
Keryx Biopharmaceuticals, Inc. (KERX) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.
This stock has had its share of gyrations. It has a 52 week high of around $5.55 and has a bunch of followers and investors who are enthusiastic about its KRX-0401 (perifosine), an oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K).
Note that the stock did not move based on the KRX-0401 today. KERX moved today on news about their drug Zerenex (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. Zenerex got a positive review from a study in Japan thereby causing the stock to react positively. Is there more in the tank?
This stock has a 200 day moving average of $3.27, and a 50 day moving average of $3.23. Can the stock rally back to these levels on this positive study?
Sign up for our newsletter and get our charts and profiles today!
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
Share this Instablog
Latest Followers
StockTalks
-
$FREE is exploding http://bit.ly/Ij9trD
Apr 12, 2012
-
$PLUG is one stock to watch tomorrow. http://bit.ly/HJvodM
Apr 12, 2012
-
Anyone watching $SNPK? http://bit.ly/Hz8mXp
Apr 10, 2012
More »Latest Comments
Most Commented
Posts by Themes